机构：[1]Precision Medicine Key Laboratory of Sichuan Province and Precision Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.四川大学华西医院[2]Department of Information Center and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.四川大学华西医院[3]State Key Laboratory of Proteomics, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 100850, China.[4]State Key Lab of Bioelectronics, National Demonstration Center for Experimental Biomedical Engineering Education, School of Biological Science and Medical Engineering, Southeast University, Nanjing, Jiangsu 210096, China.[5]Institute of Environmental Information, Chinese Research Academy of Environmental Sciences, Beijing 100012, China.
This study was supported by the grants from National Key
Development Plan for Precision Medicine Research, China
(No. 2017YFC0910004), Sichuan Science and Technology
Program, China (No. 2017HH0044), and Chengdu
Science and Technology Program, China (No. 2017-
CY02-00017-GX).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2021]版：
大类|3 区医学
小类|3 区医学：内科
最新[2023]版：
大类|3 区医学
小类|3 区医学：内科
第一作者：
第一作者机构：[1]Precision Medicine Key Laboratory of Sichuan Province and Precision Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
通讯作者：
通讯机构：[1]Precision Medicine Key Laboratory of Sichuan Province and Precision Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.[5]Institute of Environmental Information, Chinese Research Academy of Environmental Sciences, Beijing 100012, China.[*1]Institute of Environmental Information, Chinese Research Academy of Environmental Sciences, Beijing 100012, China[*2]Precision Medicine Key Laboratory of Sichuan Province and Precision Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China
推荐引用方式(GB/T 7714)：
Lu Sifen,Li Nan,Peng Zhiqiang,et al.Fc fragment of immunoglobulin G receptor IIa (FCGR2A) as a new potential prognostic biomarker of esophageal squamous cell carcinoma.[J].Chinese Medical Journal.2021,135(4):482-484.doi:10.1097/CM9.0000000000001776.
APA：
Lu Sifen,Li Nan,Peng Zhiqiang,Lu Zuhong,Tu Xingyue...&Kang Yulin.(2021).Fc fragment of immunoglobulin G receptor IIa (FCGR2A) as a new potential prognostic biomarker of esophageal squamous cell carcinoma..Chinese Medical Journal,135,(4)
MLA：
Lu Sifen,et al."Fc fragment of immunoglobulin G receptor IIa (FCGR2A) as a new potential prognostic biomarker of esophageal squamous cell carcinoma.".Chinese Medical Journal 135..4(2021):482-484
